Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoprinosine versus placebo for acute respiratory viral infections
2014-001863-11Phase 3Completed
- Sponsor
- Ewopharma
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Respiratory viral illness, influenza, respiratory syncytial virus disease (RSV) and 2 more comparing Isoprinosine with Placebo (2 arms). Primary endpoint: Time to resolution of all influenza-like symptoms present at baseline to none. Started Jun 2014; status: completed.
02
Drugs
inosine pranobex
03
Conditions
Respiratory viral illnessinfluenzarespiratory syncytial virus disease (RSV)adenoviral infectionparainfluenza virus infection
Beyond the preview
Go deeper on 2014-001863-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001863-11.